Efzofitimod for the Treatment of Pulmonary SarcoidosisDaniel A. Culver, Robert P. Baughman, W. Ennis James et al.|CHEST Journal|2022Cited by 57
Use of ranolazine in patients with incomplete revascularization after percutaneous coronary intervention: Design and rationale of the Ranolazine for Incomplete Vessel Revascularization Post–Percutaneous Coronary Intervention (RIVER-PCI) trialGiora Weisz, Gregg W. Stone, Ramin Farzaneh‐Far et al.|American Heart Journal|2013Cited by 23